THE PRESENCE of tissue-specific antigen in various mucins has been demonstrated in a number of studies (Bara et al., 1977; Hillermanns, 1962; Nairn et al., 1962) . Antibodies to mucins from alimentary tract can be readily produced and shown by immunofluorescence to localize to endosecretory parts of the epithelial cells. More recently, Gold & Miller (1978) showed that, while common gastrointestinal specific antigens are present throughout the GI tract, mucoproteins from regions neighbouring the colon have a greater structural similarity than those from GI regions distant from the colon. The antigenic characterization of mucus from the endocervix, and in particular the antigenic (lifferentiation between endocervical and endometrial mucus, has not been adequately investigated. In this commuLnication we describe the production of a specific antiserum to endocervical mucus, which can differentiate normal as well as neoplastic endocervical from endometrial tissue.
Endocervical (Fig. 1) . The staining in the frozen sections was much brighter and more abundant than in paraffin sections. All sections tested (13 patients) showed linear staining of the free glandular surface, with no free mucus staining (Fig. 2) . There was no staining of endometrial sections (21 patients) irrespective of stage of proliferation or secretion. Sections of adenocarcinoma of endocervical origin (10 patients) showed bright fluorescence, whereas there was no fluorescence in sections of carcinoma of the endometrium (9 patients) (Figs 3 & 4) .
These findings indicate that an antiserum specific to endocervical mucus can distinguish between normal and neoplastic endocervical tissue from tumours arising in the bodv of the uterus. This could be of value when the origin of the tumour is in doubt. Although, in general, malignant transformation has been associated with some loss of organ-specific antigens, complete depletion of mucus secretion is unlikely. Fully antigenic cells could be found in a few acini in malignant-tumour studies by Nairn (1976) as well as in a proportion of carcinomas studied by Lord (1962) . Likewise, Goldenberg et al. (1975) have recently identified a colon-specific antigen (CSA) which is present in both normal and tumour tissue. This agrees with our findings that endocervical-specific mucus antigen is present in both normal and cancer cells in the cervix. This does not deny the presence of immunologically specific tumour mucins distinct from normal mucins (Gold & Miller, 1975) .
Although oestrogenic and progestogenic phases of the menstrual cycle are associated with considerable changes in the constitution of endocervical mucus, we could not detect any changes in sections of the endocervix stained by this antiserum. Likewise, sections of endocervix from postmenopausal patients did not stain any differently from pre-menopausal patients.
Although the exact nature of the antigen detected by this antiserum has not been fully characterized, it is unlikely that the antiserum is detecting CEA, since anti-CEA sera do not stain normal endocervical tissue.
It is concluded that an antiserum to endocervical mucus, as described above, could be useful in distinguishing the histogenetic origin of tumours of the uterus, in snap-frozen as well as in paraffin embedded sections. Whether mucusrelated antigens are present in the circulation in high enough concentration to be detected by sensitive techniques remains to be established. Investigation is now in progress into the possibility of establishing a radioimmunoassay technique for the detection of purified endocervix-specific glycoproteins in the plasma of patients with endocervical cancer.
